INFI
Infinity Pharmaceuticals, Inc.
INFI
INFI
Delisted
INFI was delisted on the 13th of September, 2023.
63 hedge funds and large institutions have $58.1M invested in Infinity Pharmaceuticals, Inc. in 2019 Q1 according to their latest regulatory filings, with 9 funds opening new positions, 14 increasing their positions, 17 reducing their positions, and 10 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more capital invested
Capital invested by funds: $ → $
less funds holding
Funds holding: →
less first-time investments, than exits
New positions opened: | Existing positions closed:
18% less repeat investments, than reductions
Existing positions increased: 14 | Existing positions reduced: 17
Holders
63
Holding in Top 10
1
Calls
$131K
Puts
$7K
Top Buyers
| 1 | +$340K | |
| 2 | +$307K | |
| 3 | +$151K | |
| 4 |
Renaissance Technologies
New York
|
+$130K |
| 5 |
Jacobs Levy Equity Management
Florham Park,
New Jersey
|
+$118K |
Top Sellers
| 1 | -$346K | |
| 2 | -$172K | |
| 3 | -$91.6K | |
| 4 |
Citadel Advisors
Miami,
Florida
|
-$65.9K |
| 5 |
AIM
Alambic Investment Management
Belvedere,
California
|
-$46K |